Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS

Adeno-associated virus (AAV) has emerged as a leading platform for gene therapy. With the skyrocketing rate of AAV research and the prevalence of many new engineered capsids being investigated in preclinical and clinical trials, capsid characterization plays a vital role in serotype confirmation and...

Full description

Bibliographic Details
Main Authors: Anh K. Lam, Junping Zhang, Dylan Frabutt, Patrick L. Mulcrone, Lei Li, Lifan Zeng, Roland W. Herzog, Weidong Xiao
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050122001334
_version_ 1811241501269688320
author Anh K. Lam
Junping Zhang
Dylan Frabutt
Patrick L. Mulcrone
Lei Li
Lifan Zeng
Roland W. Herzog
Weidong Xiao
author_facet Anh K. Lam
Junping Zhang
Dylan Frabutt
Patrick L. Mulcrone
Lei Li
Lifan Zeng
Roland W. Herzog
Weidong Xiao
author_sort Anh K. Lam
collection DOAJ
description Adeno-associated virus (AAV) has emerged as a leading platform for gene therapy. With the skyrocketing rate of AAV research and the prevalence of many new engineered capsids being investigated in preclinical and clinical trials, capsid characterization plays a vital role in serotype confirmation and quality control. Further, peptide mapping the capsid proteins might inevitably be a future requirement by regulatory agencies since it is a critical step in good manufacturing practice (GMP) for biotherapeutic characterization. To overcome many challenges that traditional methods like SDS-PAGE and western blots carry, liquid chromatography and mass spectrometry (LC-MS) allows high resolution and sensitivity with great accuracy in characterizing the AAV capsid proteins. Our optimized LC-MS method provides quick sample preparation, a fast and high-throughput 4-min run, and high sensitivity, which allows for very efficient characterization of wild-type and engineered capsids. This study also reports the usage of LC-MS/MS peptide mapping of AAV capsid proteins to determine the most accessible lysine residues targeted by chemical modifications. Our detailed protocols are anticipated to promote the development and discovery of AAV variants with high accuracy and efficiency.
first_indexed 2024-04-12T13:37:07Z
format Article
id doaj.art-19ab892021054159a919044b17f3e279
institution Directory Open Access Journal
issn 2329-0501
language English
last_indexed 2024-04-12T13:37:07Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Molecular Therapy: Methods & Clinical Development
spelling doaj.art-19ab892021054159a919044b17f3e2792022-12-22T03:30:57ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012022-12-0127185194Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MSAnh K. Lam0Junping Zhang1Dylan Frabutt2Patrick L. Mulcrone3Lei Li4Lifan Zeng5Roland W. Herzog6Weidong Xiao7Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USADepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USADepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USADepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USADepartment of Chemistry, Georgia State University, Atlanta, GA 30302, USADepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USADepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USADepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Corresponding author. Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.Adeno-associated virus (AAV) has emerged as a leading platform for gene therapy. With the skyrocketing rate of AAV research and the prevalence of many new engineered capsids being investigated in preclinical and clinical trials, capsid characterization plays a vital role in serotype confirmation and quality control. Further, peptide mapping the capsid proteins might inevitably be a future requirement by regulatory agencies since it is a critical step in good manufacturing practice (GMP) for biotherapeutic characterization. To overcome many challenges that traditional methods like SDS-PAGE and western blots carry, liquid chromatography and mass spectrometry (LC-MS) allows high resolution and sensitivity with great accuracy in characterizing the AAV capsid proteins. Our optimized LC-MS method provides quick sample preparation, a fast and high-throughput 4-min run, and high sensitivity, which allows for very efficient characterization of wild-type and engineered capsids. This study also reports the usage of LC-MS/MS peptide mapping of AAV capsid proteins to determine the most accessible lysine residues targeted by chemical modifications. Our detailed protocols are anticipated to promote the development and discovery of AAV variants with high accuracy and efficiency.http://www.sciencedirect.com/science/article/pii/S2329050122001334AAVcapsid characterizationLC-MSpeptide mappingengineered capsidsgene therapy
spellingShingle Anh K. Lam
Junping Zhang
Dylan Frabutt
Patrick L. Mulcrone
Lei Li
Lifan Zeng
Roland W. Herzog
Weidong Xiao
Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
Molecular Therapy: Methods & Clinical Development
AAV
capsid characterization
LC-MS
peptide mapping
engineered capsids
gene therapy
title Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
title_full Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
title_fullStr Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
title_full_unstemmed Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
title_short Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MS
title_sort fast and high throughput lc ms characterization and peptide mapping of engineered aav capsids using lc ms ms
topic AAV
capsid characterization
LC-MS
peptide mapping
engineered capsids
gene therapy
url http://www.sciencedirect.com/science/article/pii/S2329050122001334
work_keys_str_mv AT anhklam fastandhighthroughputlcmscharacterizationandpeptidemappingofengineeredaavcapsidsusinglcmsms
AT junpingzhang fastandhighthroughputlcmscharacterizationandpeptidemappingofengineeredaavcapsidsusinglcmsms
AT dylanfrabutt fastandhighthroughputlcmscharacterizationandpeptidemappingofengineeredaavcapsidsusinglcmsms
AT patricklmulcrone fastandhighthroughputlcmscharacterizationandpeptidemappingofengineeredaavcapsidsusinglcmsms
AT leili fastandhighthroughputlcmscharacterizationandpeptidemappingofengineeredaavcapsidsusinglcmsms
AT lifanzeng fastandhighthroughputlcmscharacterizationandpeptidemappingofengineeredaavcapsidsusinglcmsms
AT rolandwherzog fastandhighthroughputlcmscharacterizationandpeptidemappingofengineeredaavcapsidsusinglcmsms
AT weidongxiao fastandhighthroughputlcmscharacterizationandpeptidemappingofengineeredaavcapsidsusinglcmsms